AGL vs MD
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AGL · Agilon Health$113.39 ▼ 0.33%
MD · Pediatrix Medical$31.29 ▼ 1.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AGL +588.3%
- MD +38.6%
Head to head
| Metric | AGL | MD |
|---|---|---|
| Price | $113.39 | $31.29 |
| Change today | ▼ 0.33% | ▼ 1.73% |
| Market cap | $1.90B | $2.44B |
| Return, 3 months | +17.2% | +20.0% |
| Return, year to date | +558.3% | +46.3% |
| Return, 1 year | +580.0% | +42.7% |
| P/E (TTM) | – | 17.1 |
| P/B | 6.8 | 2.9 |
| P/E percentile vs own 5y | 64th | 79th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +7.2% | +1.7% |
| Net profit growth (YoY) | +117.2% | -34.5% |
| Gross margin | 0.2% | 26.1% |
| Operating margin | -4.6% | 12.1% |
| Net margin | -3.9% | 7.7% |
| Return on equity | -73.0% | 17.2% |
| Analyst target vs. price | +3.7% | -12.4% |
| Analyst buy share | 25% | 17% |
| RSI (14) | 77 | 67 |
| 30-day volatility | 64.1% | 32.8% |
| Max drawdown, 1 year | -69.0% | -23.7% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MD is the largest of the group by market value.
- AGL has returned the most over the past year.
- AGL is growing revenue fastest.
- MD keeps the most profit per dollar of sales.
- MD has been the calmest stock over the last 30 days.